SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Oct 17, 2013
Insider Transaction Report
Form 4
Bahrt Kenneth
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2013-10-16$0.07/sh−1,600$116→ 106,400 total - Sale
Common Stock
2013-10-16$0.07/sh−500$36→ 100,000 total - Sale
Common Stock
2013-10-15$0.08/sh−661$54→ 111,911 total - Sale
Common Stock
2013-10-15$0.08/sh−65,639$5,336→ 112,572 total - Sale
Common Stock
2013-10-16$0.07/sh−3,500$261→ 102,900 total - Sale
Common Stock
2013-10-15$0.08/sh−3,911$322→ 108,000 total - Sale
Common Stock
2013-10-16$0.07/sh−2,400$176→ 100,500 total